Detailing Priorities Cardiologists Priority 1 November Aurora December Aurora January Xavor-DIU February Xavor-DIU Physicians/Diabetologists Priority Month

1 Month November December January February Aurora Aurora Xavor-DIU Xavor-DIU Priority 2 Xavor-DIU Xavor-DIU Aurora Aurora Priority 2 Xavor-DIU Xavor-DIU Aurora Aurora Priority 2 Xavor-DIU Xavor-DIU Aurora Aurora Priority 2 Aurora Aurora Aurora Aurora Priority 3 Orlis Orlis Orlis Orlis Priority 3 Orlis Orlis Orlis Orlis Priority 3 Orlis Orlis Orlis Orlis Priority 3 Priority 4 Priority 4 Priority 4 Reminder 1 Atenorm Atenorm Atenorm Atenorm Reminder 1 Atenorm Atenorm Atenorm Atenorm Reminder 1 Atenorm Atenorm Atenorm Atenorm Reminder 1 Xavor-DIU Xavor-DIU Xavor-DIU Xavor-DIU

Priority 4

General Practitioners Priority Month 1 November December January February Gynecologists Month November December January February Aurora Aurora Xavor-DIU Xavor-DIU Priority 1 Orlis Orlis Orlis Orlis

ARBs are the most prescribed antihypertensive and Losartan is leading them With 1.5 Billion sales in 1 year and growing by 17.5%. (MAT Q-2 2013)

Indications:
Hypertension Reduction in risk of stroke in hypertensive patients with LVH Diabetic Nephropathy Hypertension with CHF Hypertension with Diabetes

Unique Selling Points:

Xavor Provides Benefits Beyond Hypertension Control Provides Significant reduction in risk of Stroke by 25% as confirmed by LIFE study Provides Significant reduction in ESRD by 47% in non diabetic hypertensive Patients as per Int. Journal of Nephrology & Renovascular Disease 2010 Significant reduction in ESRD by 28% in diabetic hypertensive patients as confirmed by RENAAL study 32% risk reduction in incidence of 1st Hospitalization for Heart Failure in Type II Diabetic patients (RENAAL) 35% Reduction in Proteinuria in NIDDM Patients with Hypertension (RENAAL) 25% Risk Reduction in New Onset of Diabetes compared to Atenolon (LIFE) Xavor is Economical Compared to other Brands of Losartan Potassium. Ferzosons Quality backed by confidence of doctors Xavor Detailing Scheme for Cycle II, 13-14

Page 1:
Doctor, Hypertension is just like a tip of iceberg, Its Symptoms may not be so alarming, but if untreated can lead to many life threatening complications like MI, Stroke, Renal Failure and CV Death. Doctor Its all about Protecting end Organs of your Hypertensive patients. Dr. Xavor, Xavor DIU and Xavor DIU Forte Provide Benefits beyond Hypertension control by protecting End Organs.

Page 2:
Dr. Xavor/DIU/Forte not only provides optimal BP control but also prevent patients from STROKE. Dr! in famous LIFE Study which was done on > 9,000 Patients & published in Lancet , Xavor based therapy provided optimal blood pressure control with a significant reduction in risk of Stroke by 25% compared to Beta Blocker. Hence Xavor, Xavor/DIU & Xavor-DIU FORTE provide Cardiovascular Protection to your hypertensive patients.

Page 3:
Dr. As per Int. Journal of Nephrology & Renovascular Disease 2010, Xavor Based therapy provided 47% reduction in ESRD in non-diabetic Hypertensive Patients. Moreover in another famous RENAAL Study published in NEJM, Xavor based therapy provided 28% reduction in End Stage Renal Disease in diabetic hypertensive patients. Hence, Xavor, Xavor/DIU & Xavor-DIU FORTE provide Renal Protection to your Hypertensive patients with & without Diabetes.

CLOSE & COMMITMENT

Dr. Xavor is also Economical compared to other Brands, so enhances patients compliance. I am sure, keeping in view these survival benefits & Compliance; you will prescribe XAVOR/XAVOR-DIU & XAVOR-DIU FORTE in your next coming Hypertensive patients.

Xavor Short Calls

1-15 Nov: Dr. Xavor, Xavor DIU & Xavor DIU Forte Provides Benefits beyond Hypertension Control.
As per journal of Nephrology & Renovascular disease, Xavor Provides Reduction of 47% in ESRD in nondiabetic Hypertensive Patients and 28% reduction in ESRD in Type II Diabetic Hypertensive Patients. I am sure you will Prescribe Xavor in New Hypertensive Patients .

16-30 Nov: Dr. As per LIFE Study Xavor based therapy provided significant reduction of 25% in the Risk
of STROKE Compared to Beta-blocker

1-15 DEC: Dr. Xavor not only provides Quality, But also Economy. Xavor is Economical compared to
other Brands of Losartan, thus increases compliance of your hypertensive patient.

16-31 DEC: Dr. as per LIFE Study, Xavor Provides 25% Risk reduction in New Onset of Diabetes in
Hypertensive Patients compared to Betablocker.

1-15 JAN: Dr. as per RENAAL Study, Xavor Provides 35% over all Risk reduction in proteinuria in Type-II
Hypertensive Patients.

16-31 JAN: Dr. as per RENAAL Study, Xavor Provides 32% risk reduction in 1st Hospitalization for Heart
Failure in Type-II Diabetic Hypertensive patients.

1-14 FEB: Dr. as per Int. journal of Nephrology & Reno vascular disease 2010, Xavor Provides a
Significant Reduction of 47% in ESRD in non-diabetic-Hypertensive Patients.

15-28 FEB: Dr. as per Int. journal of Nephrology & Reno vascular disease 2010, Xavor provides optimum
BP Control along with Antiplatelet effects. Xavor has also beneficial effects on Uric Acid in Hypertensive patients. NOTE: Please add Underlined 2 lines in Visit I short call in all above mentioned visits

Printing Material PDA (Nov) Drop Cards (Dec 3rd Week) Study Folders ( Nov 3rd Week) Prescription Pads( Oct) Patient Awareness leaflets

Quantity/HCR 02 300 17/HCR 15/HCR / HCR

Physician Samples (Nov & Dec) Orlis Giveaways Leather Tissue Containers(Oct 1st Week) Ladies Bag /Kit (Nov 1st Week) Orlis Pen December (2nd Week)

Quantity/HCR 50 Quantity/HCR ASM Allocation 10/ HCR ASM/ Allocation

Target Audience:
Gynecologists Diabetologists Physicains Cardiologists

Indications:
Weight reducer for overweight and obese patients Patients reported with PCO Obese patients to avoid Type 2 Diabetes and CHD risks

Unique Selling Points:

Local mechanism of action Orlis is safe and effective treatment for overweight and obese patients Orlis provides beneficial effects on metabolic syndrome (Hypertension and Hyperlipidemia) Orlis has proven efficacy for women with PCOS Orlis One Capsule with each main meal

Short Call-1
Orlis which contains Orlistat 120 mg is safe and effective treatment for overweight and obese patients. It blocks 30% fats absorption from diet. Orlis provides beneficial effects on metabolic syndrome (hypertension, type 2 diabetes and hyperlipidemia). Dosage is 1 capsule with each main meal. I believe your 1st choice for overweight and obese patients would be Orlis.

Short Call-2
Orlis which contains Orlistat 120 mg is safe and effective treatment for overweight and obese patients. It blocks 30% fats absorption from diet. In PCO patients Orlistat combined with lifestyle changes induces substantial weight loss in women with PCOS, resulting in improvements in IR, hyperandrogenemia and cardiovascular risk factors. I believe your 1st choice for PCOS, patients would be Orlis.

ORLIS DETAILING GUIDE Cycle Meeting Oct- 2013 Page 1

Doctor! Recently American Medical Association has declared obesity as a disease. Your prime objective is to save your patient from obesity related risk factors Diabetes and CVS risk. Orlis helps your patients to Lose Weight & Stay Healthy.

Page 2
Doctor! Obesity is a center piece of Metabolic Syndrome Jigsaw Puzzle and has a negative impact on CV health and mortality as compared to patients with no metabolic syndromes

Page 3
Doctor! Orlis provides beneficial effects on Metabolic Syndrome risk factors. In famous XXL study, more than 80% of obese patients lose their weight from 5%-20% with beneficial effects on hypertension and dyslipidemia.

COMMITMENT These life-saving benefits strongly recommend Orlis as an ideal treatment for your Overweight and obese patients. The recommended dosage is, one capsule of Orlis with each main meal.

GYNECOLOGIST
Dr. Orlistat is weight reducer for overweight and obese patients and where women reported with Polycystic ovarian syndrome Orlistat showed significant improvement in weight loss, improving IR, hyperandrogenemia and CVS risk factors.

PDA. PAGE 1----------- Page 2---------- Page 3-------------------

Target Audience:
Cardiologists Physicians Diabetologist / Endocrinologists Neuro Physicians MOs (Cardiology, Medicine, Nephro, Neuro) GPs (A Class)

Indications:
Patients with primary hypercholesterolemia and mixed dyslipidemia as an adjunct to diet Patients with hypertriglyceridemia as an adjunct to diet Slowing the Progression of Atherosclerosis Homozygous Familial Hypercholesterolemia Risk reduction of MI, Stroke and Arterial Revascularization procedures in patients without clinically evident CHD, but with multiple risk factors

Short Call-1
Dr! today I am here to introduce Aurora (Rosuvastatin) available in 5mg, 10mg & 20mg, an ideal choice for your patients with dyslipidemia. Aurora based therapy increase HDL 7.7%as compared to Atorvastatin 2.1% and reduces LDL-C 45% with only 10mg dose as compared to any other statins. This ensures a maximum protection to your dyslipidemic patient from CV events supported by famous JUPITER TRIAL. It is cost-effective and economical as compared to Atorvastatin. I am sure, keeping in view the life saving benefits; Aurora will be your fist choice for newly diagnosed and in follow up patients with dyslipidemia.

AURORA DETAILING GUIDE Cycle Meeting Oct- 2013

Page 1
Doctor! As you know for hyperlipidemic patients HDL-C and LDL-C both needs to be managed. Aurora contains (ROSUVASTATIN) raises HDL and lowers LDL more effectively as compared to other statins. Rosuvastatin provides life saving benefits to dyslipidemia patients

Page 2

Dr! according to AACC Guidelines 2012, for the management of dyslipidemia and prevention of atherosclerosis, the patients with Diabetes are considered to be on a high risk of developing CHD with a LDL treatment goal of < 100mg/dl and Aurora which contains Rosuvastatin decrease LDL 45% more than any other statin.

Doctor! Aurora improves all lipid parameters at 10 mg , Aurora increase HDL-C 7.7% as compared to Atorvastatin 2.1% . These results make Aurora(Rosuvastatin) superior than other statins 9

Page 3

Doctor! JUPITER study is a trial on ROSUVASTSTIN says Aurora significantly reduces CV events and mortality 1. 47% reduction in CV risk 2. 48% reduction in stroke The recommended dosage is 10 mg once a day and maximum 40mg. Aurora is available in 5mg, 10mg and 20 mg at economical price than other brands.

COMMITMENT
Dr! I am sure, keeping in view the life saving benefits; Aurora will be your fist choice for newly diagnosed and in follow up patients with dyslipidemia

10